Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (121-130 of 211) with videos related to

Pageof 22
Sort By:
European Journal of Cancer & Clinical Oncology|January 1, 1983
A phase II trial of peplomycin in squamous cell carcinoma of the lungP G Sørensen, M Rørth, H H Hansen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II study of teniposide in advanced breast cancerJ Boas, D Rasmussen, O P Hansen, et al.
Ugeskrift for Laeger|July 29, 1974
[Bone marrow biopsy with Radner's needle. A new method for bone marrow examination]A M Worm, P Dombernowsky, B Hainau, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lungF Bach, J Vibe-Petersen, J B Sørensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
TCNU in adenocarcinoma of the lung: a phase II study with divided dosesJ B Sørensen, F Bach, P Dombernowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized studyE Bork, J Ersbøll, P Dombernowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patientsU Lassen, K Osterlind, M Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancerM Ryberg, D Nielsen, T Skovsgaard, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancerF Bach, F W Bach, A G Pedersen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 24, 2001
Biological variation and analytical imprecision of CA 125 in patients with ovarian cancerM K Tuxen, G Sölétormos, G J Rustin, et al.
Pageof 22

Showing results (121-130 of 211) with videos related to

Sort By:
Pageof 22
European Journal of Cancer & Clinical Oncology|January 1, 1983
A phase II trial of peplomycin in squamous cell carcinoma of the lungP G Sørensen, M Rørth, H H Hansen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II study of teniposide in advanced breast cancerJ Boas, D Rasmussen, O P Hansen, et al.
Ugeskrift for Laeger|July 29, 1974
[Bone marrow biopsy with Radner's needle. A new method for bone marrow examination]A M Worm, P Dombernowsky, B Hainau, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1990
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lungF Bach, J Vibe-Petersen, J B Sørensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1990
TCNU in adenocarcinoma of the lung: a phase II study with divided dosesJ B Sørensen, F Bach, P Dombernowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized studyE Bork, J Ersbøll, P Dombernowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patientsU Lassen, K Osterlind, M Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancerM Ryberg, D Nielsen, T Skovsgaard, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancerF Bach, F W Bach, A G Pedersen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 24, 2001
Biological variation and analytical imprecision of CA 125 in patients with ovarian cancerM K Tuxen, G Sölétormos, G J Rustin, et al.
Pageof 22